Patent ID: 7622484
Filing Date: 2009-11-24
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition comprising, (a) a compound  in free or pharmaceutically acceptable salt; and (b) mometasone furoate, for simultaneous administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (a) to (b) being from 3:1 to 1:7 and a pharmaceutically acceptable carrier; which is in inhalable form and is: (i) an aerosol comprising a mixture of (a) and (b) in solution or dispersion in a propellant; (ii) a combination of an aerosol containing (a) in solution or dispersion in a propellant with an aerosol containing (b) in solution or dispersion in a propellant; (iii) a nebulizable composition comprising a dispersion of (a) and (b) in an aqueous, organic or aqueous/organic medium; or (iv) a combination of a dispersion of (a) in an aqueous, organic or aqueous/organic medium with a dispersion of (b) in an aqueous, organic or aqueous/organic medium.